Brixton Biosciences

About:

Brixton Biosciences is a clinical-stage life sciences company that develops therapies for chronic and acute pain.

Website: https://www.brixtonbio.com/=

Top Investors: National Institutes of Health, SV Health Investors, Schooner Capital, Sparta Group, Excelestar Ventures

Description:

Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for pain treatment. Backed by deep research, the company addresses crucial unmet needs in pain management, which has historically been dominated by systemic medicine. Brixton Biosciences' innovative therapeutics, such as its novel Neural Ice™, provide pain relief in a single, safe, and easy drug-free injectable that is a non-addictive, locally targeted, and comparatively long-lasting solution.

Total Funding Amount:

$35M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)brixtonbio.com

Founders:

Lilit Garibyan, R. Rox Anderson, Sameer Sabir

Number of Employees:

1-10

Last Funding Date:

2024-10-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai